#Regulatory Issues

[grandwretch]

I know that I am on a watch list because when I'm inconvenienced I start threatening what is essentially Hollywood's view of terrorism

[wall-of-knowledge]

Problems caused by Excessive groundwater withdrawal

Table of Contents Key PointsDirect AnswerWhat Happens When We Take Too Much Groundwater?Real-World ExamplesUnexpected DetailComprehensive Analysis of Excessive Groundwater Withdrawal IssuesBackground and ImportanceDetailed Problems Caused by Excessive WithdrawalCase Studies: Ogallala Aquifer and IranComparative AnalysisMitigation Strategies and Future OutlookConclusionKey Citations Key…

[manuelnunezmd]

Navigating the World of Direct-to-Consumer Healthcare Products: Empowerment and Ethical Considerations

Dive into the world of direct-to-consumer healthcare! In this article, we explore the ethical issues surrounding DTC healthcare products, the empowerment of consumers through digital health platforms, and the challenges and opportunities in direct-to-consumer telemedicine. Learn about the importance of ethical considerations in direct-to-consumer healthcare products. With the rise of DTC healthcare products, it's crucial to be an informed consumer. Before you click that "Buy Now" button, do your homework. Check for certifications, read reviews, and consult with healthcare professionals. Remember, your health is not something to gamble with. Discover how digital health platforms are revolutionizing the way we access and manage our health information. These platforms provide consumers with direct access to health-related data and services, bypassing traditional intermediaries like insurance companies and clinicians. This shift empowers consumers to take a more active role in managing their health. Explore the challenges and opportunities in direct-to-consumer telemedicine. Telemedicine offers convenience and accessibility, especially in remote areas where traditional healthcare infrastructure is limited. With just a few taps on your smartphone, you can connect with a healthcare provider and get the care you need. Stay informed and empowered in your healthcare journey. Your health is your most valuable asset, so make wise choices. If you have any questions or need further information, feel free to reach out. Until next time, stay healthy and stay curious! You can now copy and paste the entire article into your WordPress editor. If you need any further assistance or have any questions, feel free to ask!

Navigating the World of Direct-to-Consumer Healthcare Products: Empowerment and Ethical Considerations Introduction Welcome to the wild world of direct-to-consumer (DTC) healthcare products! In this brave new world, you can order anything from genetic tests to teeth alignment kits with just a few clicks. But hold your horses—or in this case, your prescription pads—because with great power comes…

[adsbim]

Architectural Design Development : Process, Challenges, and Solutions

Architectural Design Development is a crucial phase in the architectural workflow, bridging the gap between conceptual design and construction documentation. At ADSBIM, we specialize in Architectural Design Development Services across India, the UK, the USA, and the UAE, ensuring high-quality, efficient, and cost-effective solutions for architects, designers, and construction firms.

This blog explores the process of architectural design development, common challenges faced in the industry, and how ADSBIM provides innovative solutions using advanced BIM technology and industry-leading software.

The Architectural Design Development Process

The Design Development phase is where the initial architectural concept is refined, detailed, and prepared for construction documentation. It involves:

1. Concept Development & Refinement

Translating initial sketches into detailed 3D models.

Incorporating client feedback and refining design iterations.

Ensuring compliance with zoning laws, building codes, and sustainability standards.

2. Spatial Planning & Technical Detailing

Defining the dimensions and arrangement of spaces.

Developing structural, mechanical, electrical, and plumbing (MEP) layouts.

Ensuring coordination between different disciplines for seamless execution.

3. Material Selection & Specification

Selecting appropriate building materials for sustainability and cost-effectiveness.

Specifying finishes, textures, and other aesthetic elements.

4. BIM Integration for Design Validation

Utilizing Building Information Modeling (BIM) to validate the design before construction.

Detecting and resolving clashes between architectural, structural, and MEP systems.

Enhancing collaboration between architects, engineers, and contractors.

5. Construction Documentation & Approval

Creating detailed architectural drawings, sections, and elevations.

Preparing permit drawings for government approvals.

Finalizing construction-ready blueprints.

Challenges in Architectural Design Development

Despite its importance, the design development phase presents multiple challenges, including:

 Design Coordination Issues

Ensuring seamless coordination between architectural, structural, and MEP systems is complex.

Solution: ADSBIM employs BIM for Design Development Services to integrate all disciplines in a single model, reducing errors.

 Lack of Visualization & Design Validation

Traditional 2D drawings often lead to misinterpretation.

Solution: We use 3D modeling, rendering, and virtual walkthroughs to provide realistic previews of the final project.

Time and Cost Overruns

Frequent design changes and errors lead to increased costs and delays.

Solution: Our BIM-based clash detection and real-time design collaboration minimize changes during construction.

Sustainability

Adhering to different building codes across India, the UK, the USA, and the UAE is challenging.

Solution: ADSBIM ensures compliance through automated code-checking tools and sustainable material selection.

Tools & Software We Use

At ADSBIM, we leverage industry-leading tools to enhance our Architectural Design Services:

Autodesk Revit – For detailed BIM modeling, coordination, and documentation. AutoCAD – For 2D drafting and construction drawings. SketchUp – For conceptual design and 3D visualization. Navisworks – For clash detection and design validation. Lumion/Enscape – For high-quality 3D rendering and walkthroughs. Dynamo for Revit – For automation and parametric modeling.

By utilizing these tools, we streamline the Architectural Design Development process and deliver efficient, error-free designs.

FAQs 

1 What is Architectural Design Development?

Architectural Design Development is the process of refining the conceptual design into a detailed, construction-ready blueprint, incorporating spatial planning, technical detailing, and material selection.

2 How does BIM help in Architectural Design Development?

BIM (Building Information Modeling) enhances design accuracy, coordination, and visualization, ensuring smooth collaboration between architects, engineers, and contractors.

3 What industries benefit from Architectural Design Development services?

Architectural Design Development services are essential for residential, commercial, industrial, healthcare, and hospitality projects.

Conclusion

The Architectural Design Development phase is critical in bringing conceptual ideas to life while ensuring technical accuracy and feasibility. At ADSBIM, we specialize in BIM for Design Development Services, enabling architects and developers to achieve efficient, cost-effective, and high-quality designs.

If you’re looking for Architectural Design Development Services in India, the UK, the USA, or the UAE, contact ADSBIM today and let us help you transform your vision into reality!

🚀 Get in Touch for Expert BIM Solutions! 🚀

[hmsharmony]

1) This is not an executive order. NIST is requesting comments for the factors it will consider when enforcing regulations promulgated under the Bayh-Doyle Act and Executive Order 12591. Notice and comment is generally for proposed rulemaking. Executive orders, meanwhile, are just that—orders. They don’t ask for public comment, nor is such comment necessary for an executive order to take effect (see, for example, all the executive orders bringing back sanctions on Iran when we left the JCPOA, or announcing new sanctions on Russia after the invasion of Ukraine). With proposed agency rulemaking, however, most* cannot go into force without a notice and public comment period, after which the relevant agency has to review every single comment. When the agency passes the final rule, the preamble summarizes the comments and explains how the final rule addresses the concerns raised in those comments (or why doing so wasn’t necessary).

*There are exceptions, but trying to avoid turning this into an admin law lecture.

2) Reviewed the federal register notice and confirmed the comment portal linked above is correct.

3) To make sure your comment conforms with requirements/is useful to NIST, I would read the federal register notice itself, linked in 2), particularly pages 2 and 6-7.

4) Agency rulemaking is subject to judicial review. What this means, in practice, is that if a court is hostile to expanding government intervention (other than, y’know, a woman’s reproductive system), then there’s an increased likelihood the court may say the agency exceeded its authority. Just to prepare people since this is very much a move that could be seen in that light, particularly given the current composition of SCOTUS. Historically courts have given deference to agency interpretations of statutes, known as Chevron Deference, but there are two cases on SCOTUS’ docket that could roll that back.

"The Biden Administration last week [early December, 2023] announced it would be seizing patents for drugs and drug manufacturing procedures developed using government money.

A draft of the new law, seen by Reuters, said that the government will consider various factors including whether a medical situation is leading to increased prices of the drug at any given time, or whether only a small section of Americans can afford it.

The new executive order is the first exercise in what is called “march-in-rights” which allows relevant government agencies to redistribute patents if they were generated under government funding. The NIH has long maintained march-in-rights, but previous directors have been unwilling to use them, fearing consequences.

“We’ll make it clear that when drug companies won’t sell taxpayer funded drugs at reasonable prices, we will be prepared to allow other companies to provide those drugs for less,” White House adviser Lael Brainard said on a press call.

But just how much taxpayer money is going toward funding drugs? A research paper from the Insitute for New Economic Thought showed that “NIH funding contributed to research associated with every new drug approved from 2010-2019, totaling $230 billion.”

The authors of the paper continue, writing “NIH funding also produced 22 thousand patents, which provided marketing exclusivity for 27 (8.6%) of the drugs approved [between] 2010-2019.”

How we do drug discovery and production in America has a number of fundamental flaws that have created problems in the health service industry.

It costs billions of dollars and sometimes as many as 5 to 10 years to bring a drug to market in the US, which means that only companies with massive financial muscle can do so with any regularity, and that smaller, more innovative companies can’t compete with these pharma giants.

This also means that if a company can’t recoup that loss, a single failed drug can result in massive disruptions to business. To protect themselves, pharmaceutical companies establish piles of patents on drugs and drug manufacturing procedures. Especially if the drug in question treats a rare or obscure disease, these patents essentially ensure the company has monoselective pricing regimes.

However, if a company can convince the NIH that a particular drug should be considered a public health priority, they can be almost entirely funded by the government, as the research paper showed.

Some market participants, in this case the famous billionaire investor Mark Cuban, have attempted to remedy the issue of drug costs in America by manufacturing generic versions of patented drugs sold for common diseases."

-via Good News Network, December 11, 2023

[researchers-me]

Red Flags Raised Over Surging Silver Imports from Dubai via Gift City

Red flags raised over increasing silver imports from Dubai through Gift City amid regulatory concerns.

[touchaheartnews]

Mob Vandalizes Telecom Office in Festac Town Amid SIM Blockade

On a scorching afternoon in Festac Town, Lagos, an uproarious scene unfolded at a major telecommunications office. The incident, now widely referred to as the “SIM Blockade,” involved a mob of frustrated locals who took their grievances to the streets, culminating in a significant act of vandalism against the telecom office. The root of this chaos was a recent policy change that left countless…

[alianoralacanta]

FIA Bans F1 Cars (24-08-2006)

Context: the championship-contending (and eventually championship-winning) Renault R26 received a setback when the FIA banned its integrated mass damper during the summer break. This was a device with an internal weighted element that shifted slightly when undergoing sufficient G-force. The argument used was that that nothing that moves could provide aerodynamic advantage. However, Newtonian physics determines that everything moves when anything touches it. Thus, everything has aerodynamic advantage and on that argument, every F1 car that has or ever could exist is illegal. This did not seem like a good idea…

So the FIA are in essence saying that a small aerodynamic advantage means that a component is not part of the fully sprung mass (or so it would appear from the proximity of the aero and sprung mass points). In other words, all components providing an aerodynamic influence are not part of the sprung mass and therefore illegal. All components have an aerodynamic influence, however small that may be.

Technically, this means that the FIA would be obliged to ban all past, present and future F1 cars and declare all results from this year forth as null and void. The prior results are protected by a rule saying that once championships and races are confirmed at an FIA meeting in November, that they cannot be modified. Were it not for this clause, then it wouldn't be so much a case of passing the championships to Maranello as passing them to Paris.

If a ruling implicitly bans all F1 cars, it probably needs a rethink…

[cerbreus]

i don't know how to explain to my doctor that the fact that it is so goddamn hard and annoying to get my prescriptions refilled is part of the issue for managing my adhd. it's never easy! it can never be easy!

[apas-95]

the whole thing with subtitles saying '(speaks foreign language)' is like. aside from logistical issues with outsourced transcription services, the solution is seemingly very obvious - just transcribe the foreign language itself. like, someone who hears the audio can, if they're familiar with the 'foreign' language, glean some understanding from it, even just from individual words that are loaned or widely known - and by transcribing it accurately, that isn't denied to those reading the subtitles. even if you can't understand anything, the experience of having a character respond 'Non, mais votre chien oui!' or ‘好久不见’ is better than having them respond '(speaks foreign language)'. just like when expletives are censored in subtitles but not in audio, it's a case of the richer, fuller experience being denied for a sanitised version compatible with a production pipeline that does not see subtitles as a method of genuinely conveying meaning, but as a regulatory requirement

[queeresthellhound]

Because polls get the most engagement I’m making a poll lol

(For the sake of this poll: a collector is anyone who *currently has* a collection of things either physically or digitally that they intentionally acquired which can be grouped together)

Please please please please pleeeeeeeaaaaaaase tell me what you collect and optionally why!!!! (This is doubly true if your collection is related to a regulatory/“special” interest!!!!!!! That’s honestly the only reason I’m making this poll, I am begging youuuuuuuuuuu

Neurodivergent related tags are for reach as I know a lot of neurodiverse people are collectors. I do try my best not to clutter those tags, if anyone has an issue with it please tell me and I’ll remove them

[mhlivenews]

मराठवाड्याचा पाणीप्रश्न पेटणार; येत्या १३ ऑक्टोबरला पाणी परिषद करणार उपोषण

म. टा. प्रतिनिधी, छत्रपती संभाजीनगर : मराठवाड्याच्या न्याय हक्काच्या पाण्यासाठी मराठवाडा पाणी परिषदेतर्फे १३ ऑक्टोबर शुक्रवारी सकाळी दहा वाजता मराठवाडा विभागीय कार्यालयासमोर एक दिवसीय लाक्षणिक उपोषण करण्यात येणार आहे.पाणी परिषदेच्या वतीने प्रसिद्धीस दिलेल्या पत्रकात म्हटले आहे, ‘हैदराबाद मुक्तिसंग्राम अमृतमहोत्सव वर्षानिमित्त १६ सप्टेंबर रोजी छत्रपती संभाजीनगर येथील मंत्रिमंडळाच्या बैठकीत…

[ms-demeanor]

Honestly it seems your issues with homeopathy would be mostly remedied if the practitioners were made to work with doctors, or had to get their own MD. Because most of them can definitely help when used properly, they just usually aren't 😬

I mean.

My issue with homeopathy specifically is that it does not work, it has no way of working, and people pay money for homeopathic "medicines" that could be spent on actual treatment and may delay starting actual treatment in favor of homeopathy.

Homeopathy is either "correctly" diluted and completely ineffective (because "correctly" made homeopathic preparations are so diluted that they don't contain any of the "curative" compounds) or are "incorrectly" diluted and are literally poison.

There are plenty of shitty MDs out there who will recommend homeopathic "medicines" or other quackery; what I would prefer is if the claims made about homeopathic medicines were examined by the FDA or similar bodies for veracity before they could be sold and if they were otherwise subject to the same kinds of regulatory scrutiny as, like, aspirin manufacturers are.

If anyone wants a basic explanation of why homeopathy doesn't work, here's an ELI5 reddit thread about the question; in particular, here's a comment by someone defending homeopathy that is comprehensively responded to with explanations of why the commenter defending homeopathy is wrong.

For more a more rigorous explanation, here is the European Academies' Science Advisory Council assessment of homeopathy; I particularly recommend looking at section three, "Key issues for evaluating and communicating evidence."